Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2025-12-29 @ 3:14 PM
Study NCT ID:
NCT00838708
Status:
COMPLETED
Last Update Posted:
2009-10-30
First Post:
2009-02-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase IIa Safety and Efficacy Study of SRD174 Cream in Patients With AD-associated Pruritus
Sponsor:
Serentis Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
P174954201CD
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Robert Tansley, Chief Medical Officer
Old Organization:
Serentis